Clyde & Co and McDonnell Boehnen Hulbert & Berghoff LLP will be hosting an onsite program from 6:15 pm to 7:00 pm on December 5, 2019 at Central Working (4th floor) in London (80 Wood Lane, White City, London W12 0BZ). The program, which will take place in conjunction with I-HUB at Imperial College London, will offer presentations on the following topics:
• Patenting In the USA: Is There Anything Patent Eligible? -- Paul Tully and Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP
• Outstanding Benefit & Inventor Compensation -- Ralph Cox
A welcome reception will precede the program and a cocktail reception will follow the program.
There is no registration fee for the program. However, those interested in attending the program must register by contacting Susan Hall at hall@mbhb.com. By registering for this event, attendees agree to Clyde & Co and MBHB processing their personal data for the purposes of facilitating the event. Additional information about the event can be found here.
"Patenting In the USA: Is There Anything Patent Eligible?" is answered by the USPTO still cranking out about half a million patents a year. I suggest a less hyperbolic title, such as "Have more than a handful of otherwise-valid diagnostic patents been held invalid under the Sup. Ct. Mayo 101 decision?"
Posted by: Paul F. Morgan | November 24, 2019 at 12:02 PM
Well, Paul, one man's hyperbole can be another man's catastrophe.
Posted by: Kevin E Noonan | November 24, 2019 at 07:54 PM
Mr. Morgan,
It is more than a little disingenuous to pretend that the "front end" continuing to crank things out addresses the "back end" of viability , especially when it comes time to try to enforce that "front end."
You have been around long enough to know better.
Posted by: skeptical | November 25, 2019 at 10:01 AM